IL6 and adrenoleukodystrophy: Although the study recruited female ALD patients whom are largely overlooked in most papers, the very small cohort size and lack of correlation with any clinical outcome measures prevented this study from being of use in assessing IL-6 and IL-8 as viable biomarkers.